Saga, Japan

Shinya Motomatsu


 

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2023

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Shinya Motomatsu: Innovator in Nucleic Acid Amplification Technology

Introduction

Shinya Motomatsu is a notable inventor based in Saga, Japan. He has made significant contributions to the field of biotechnology, particularly in the development of devices for nucleic acid amplification reactions. His innovative work has the potential to enhance various applications in medical diagnostics and research.

Latest Patents

Motomatsu holds a patent for a "Device for nucleic acid amplification reaction." This device features a casing with an upper surface that includes a sample-dripping portion for receiving a liquid sample containing nucleic acid. The design incorporates a reaction tube that projects outward from the casing and includes a storage space. Additionally, the device is equipped with a filter that carries the nucleic acid and a filter-supporting body that allows the filter to transition between different positions for optimal functionality. The device also includes an absorbing material that can be press-attached to the filter, facilitating the absorption of the liquid sample.

Career Highlights

Shinya Motomatsu is currently employed at Mizuho Medy Co., Ltd., where he continues to innovate in the field of medical technology. His work is characterized by a commitment to improving the efficiency and effectiveness of nucleic acid amplification processes.

Collaborations

Motomatsu collaborates with talented colleagues, including Kenji Narahara and Takashi Nagano. Their combined expertise contributes to the advancement of their projects and the overall success of their innovations.

Conclusion

Shinya Motomatsu's contributions to nucleic acid amplification technology exemplify the impact of innovative thinking in biotechnology. His patent and ongoing work at Mizuho Medy Co., Ltd. highlight the importance of advancements in this critical field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…